Related Experiment Videos
[The treatment of acute myocardial infarct with perlinganit]
Insights
Perlinganit effectively treats acute myocardial infarction by improving hemodynamics and reducing symptoms. This study shows its advisability for patients with heart attacks.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Acute myocardial infarction (MI) is a leading cause of mortality.
- Left ventricular insufficiency and arrhythmias are common complications of MI.
- Current treatments aim to restore blood flow and manage complications.
Purpose:
- To evaluate the clinical and hemodynamic effects of Perlinganit in patients with acute myocardial infarction.
- To assess the antianginal and antiarrhythmic properties of Perlinganit during MI treatment.
Summary:
- A study observed 43 patients with acute myocardial infarction (30 men, 13 women, aged 36-82).
- Perlinganit was administered via a drug-dosing apparatus (DDA-1) at an average infusion rate of 74.5 ± 3.4 µg/min for 51.1 ± 4.8 hours.
- Significant clinical and hemodynamic improvements were noted, including elimination of left ventricular insufficiency and normalization of contractile function within hours.
- Antianginal and antiarrhythmic effects were observed during treatment.
Impact:
- Perlinganit demonstrated significant efficacy in managing acute myocardial infarction.
- The drug improved hemodynamic parameters and alleviated clinical symptoms.
- Findings suggest Perlinganit is a recommendable therapeutic option for acute myocardial infarction.
Abstract:
As many as 43 patients with myocardial infarction were under observation. There were 30 men and 13 women aged 36 to 82 years. Of these, 26 patients had large-focal and 17 transmural myocardial infarction. Perlinganit was injected in the form of 0.1% solution by means of a drug-dosing apparatus (DDA-1). The drug infusion lasted 51.1 +/- 4.8 h on the average, the mean infusion rate was 74.5 +/- 3.4 micrograms/min. After 24 hours it was required that in 32 patients the mean infusion rate be increased 1.5-fold. The hemodynamics was assessed with the aid of tetrapolar chest rheography. Well-defined clinical and hemodynamic effects were revealed. In some patients, the clinical signs of left ventricular insufficiency could be eliminated. Contractile function of the left ventricle returns to normal within the first hours of disease. During perlinganit treatment, the antianginal and antiarrhythmic effects were recorded. The data obtained point to the fact that the use of perlinganit for the treatment of acute myocardial infarction is advisable.